| Application no. and date | 99920626.1 (espacenet) (Federated) (European Patent Register), 19990409 | | Patent/reg. no. and date | DK/EP 1085900, 20090610 | | Publication date | 20010328 | | Priority no. and date | DE 19816035, 19980409, EP 98250222, 19980618 | | EP pub. no. and date |
EP 1085900 20010328 | | Effective date | | | Applicant/owner | Roche Diagnostics GmbH, Sandhofer Strasse 116
68305 Mannheim, DE | | Applicant ref. no. | P45963DK01 | | Inventor | GOTTSCHALK, René, 5 Amtsgasse
D-65929 Frankfurt am Main, DE,
LEHMANN, Paul, Johann-Sebastian-Bach-Strasse 14
D-67549 Woems, DE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 33/06 (2006.01) , A61K 33/42 (2006.01) , A61K 38/18 (2006.01) | | Title | Anvendelse af erythropoietin til behandling af primære hæmokromatoser | | Int. application no. | EP1999002422 | | Int. publication no. | WO1999052542 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
